心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 欧洲意见书：卵圆孔未闭患者的管理

2021-01-28 国外神经内科相关专家小组（统称） EuroIntervention . 2021 Jan 28;EIJ-D-20-00785.

卵圆孔未闭

卵圆孔未闭(PFO)与许多疾病的发病机制有关，但至今只有一篇关于左循环血栓栓塞的官方意见书发表。本文作为跨学科意见书，主要提供了除了左循环血栓栓塞之外的几种PFO相关临床症状的一线方法。

中文标题：

2021 欧洲意见书：卵圆孔未闭患者的管理

英文标题：

European position paper on the management of patients with patent foramen ovale

发布机构：

国外神经内科相关专家小组（统称）

发布日期：

2021-01-28

简要介绍：

卵圆孔未闭(PFO)与许多疾病的发病机制有关，但至今只有一篇关于左循环血栓栓塞的官方意见书发表。本文作为跨学科意见书，主要提供了除了左循环血栓栓塞之外的几种PFO相关临床症状的一线方法。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 欧洲意见书：卵圆孔未闭患者的管理——减压病，偏头痛，动脉脱氧综合征以及高危临床情况.pdf)] GetToolGuiderByIdResponse(projectId=1, id=76dd51c0020a68b8, title=2021 欧洲意见书：卵圆孔未闭患者的管理, enTitle=European position paper on the management of patients with patent foramen ovale, guiderFrom=EuroIntervention . 2021 Jan 28;EIJ-D-20-00785., authorId=0, author=, summary=卵圆孔未闭(PFO)与许多疾病的发病机制有关，但至今只有一篇关于左循环血栓栓塞的官方意见书发表。本文作为跨学科意见书，主要提供了除了左循环血栓栓塞之外的几种PFO相关临床症状的一线方法。, cover=https://img.medsci.cn/2021130/1612018822383_2020535.jpg, journalId=0, articlesId=null, associationId=952, associationName=国外神经内科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jan 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>卵圆孔未闭(PFO)与许多疾病的发病机制有关，但至今只有一篇关于左循环血栓栓塞的官方意见书发表。本文作为跨学科意见书，主要提供了除了左循环血栓栓塞之外的几种PFO相关临床症状的一线方法。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=8445, tagName=卵圆孔未闭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8445, guiderKeyword=卵圆孔未闭, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5115, appHits=161, showAppHits=0, pcHits=1160, showPcHits=4954, likes=1, shares=21, comments=13, approvalStatus=1, publishedTime=Sat Jan 30 23:17:03 CST 2021, publishedTimeString=2021-01-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jan 30 23:00:31 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 14:56:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 欧洲意见书：卵圆孔未闭患者的管理——减压病，偏头痛，动脉脱氧综合征以及高危临床情况.pdf)])
2021 欧洲意见书：卵圆孔未闭患者的管理——减压病，偏头痛，动脉脱氧综合征以及高危临床情况.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=973119, encodeId=69eb9e311988, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9f5004226, createdName=xiexuejian, createdTime=Sat Jun 12 18:12:12 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969782, encodeId=d659969e8204, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/cf5b64396ba147d4aea7ea608f9198d3/c02bd27d4ef141ac99b6e8b6a5a74cba.jpg, createdBy=06f95413118, createdName=小铁1989, createdTime=Mon May 31 08:38:56 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954379, encodeId=9e719543e99a, content=对工作非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc302156663, createdName=12022708m82暂无昵称, createdTime=Wed Apr 07 08:32:27 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924117, encodeId=66e392411ed6, content=haohaoxuexiyixia, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87685391168, createdName=贺兰尚, createdTime=Wed Feb 10 22:52:10 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923249, encodeId=1d4d9232494f, content=真及时啊，正在找它, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210206/09bec44c50714aa99fcca057e007532f/345491d1e9e4465a8b0be3617b3ea5bd.jpg, createdBy=61a05458344, createdName=MrSxue, createdTime=Sat Feb 06 14:27:06 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
    2021-06-12 xiexuejian

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=973119, encodeId=69eb9e311988, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9f5004226, createdName=xiexuejian, createdTime=Sat Jun 12 18:12:12 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969782, encodeId=d659969e8204, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/cf5b64396ba147d4aea7ea608f9198d3/c02bd27d4ef141ac99b6e8b6a5a74cba.jpg, createdBy=06f95413118, createdName=小铁1989, createdTime=Mon May 31 08:38:56 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954379, encodeId=9e719543e99a, content=对工作非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc302156663, createdName=12022708m82暂无昵称, createdTime=Wed Apr 07 08:32:27 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924117, encodeId=66e392411ed6, content=haohaoxuexiyixia, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87685391168, createdName=贺兰尚, createdTime=Wed Feb 10 22:52:10 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923249, encodeId=1d4d9232494f, content=真及时啊，正在找它, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210206/09bec44c50714aa99fcca057e007532f/345491d1e9e4465a8b0be3617b3ea5bd.jpg, createdBy=61a05458344, createdName=MrSxue, createdTime=Sat Feb 06 14:27:06 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
    2021-05-31 小铁1989

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=973119, encodeId=69eb9e311988, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9f5004226, createdName=xiexuejian, createdTime=Sat Jun 12 18:12:12 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969782, encodeId=d659969e8204, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/cf5b64396ba147d4aea7ea608f9198d3/c02bd27d4ef141ac99b6e8b6a5a74cba.jpg, createdBy=06f95413118, createdName=小铁1989, createdTime=Mon May 31 08:38:56 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954379, encodeId=9e719543e99a, content=对工作非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc302156663, createdName=12022708m82暂无昵称, createdTime=Wed Apr 07 08:32:27 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924117, encodeId=66e392411ed6, content=haohaoxuexiyixia, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87685391168, createdName=贺兰尚, createdTime=Wed Feb 10 22:52:10 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923249, encodeId=1d4d9232494f, content=真及时啊，正在找它, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210206/09bec44c50714aa99fcca057e007532f/345491d1e9e4465a8b0be3617b3ea5bd.jpg, createdBy=61a05458344, createdName=MrSxue, createdTime=Sat Feb 06 14:27:06 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
    2021-04-07 12022708m82暂无昵称

    对工作非常有帮助

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=973119, encodeId=69eb9e311988, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9f5004226, createdName=xiexuejian, createdTime=Sat Jun 12 18:12:12 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969782, encodeId=d659969e8204, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/cf5b64396ba147d4aea7ea608f9198d3/c02bd27d4ef141ac99b6e8b6a5a74cba.jpg, createdBy=06f95413118, createdName=小铁1989, createdTime=Mon May 31 08:38:56 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954379, encodeId=9e719543e99a, content=对工作非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc302156663, createdName=12022708m82暂无昵称, createdTime=Wed Apr 07 08:32:27 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924117, encodeId=66e392411ed6, content=haohaoxuexiyixia, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87685391168, createdName=贺兰尚, createdTime=Wed Feb 10 22:52:10 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923249, encodeId=1d4d9232494f, content=真及时啊，正在找它, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210206/09bec44c50714aa99fcca057e007532f/345491d1e9e4465a8b0be3617b3ea5bd.jpg, createdBy=61a05458344, createdName=MrSxue, createdTime=Sat Feb 06 14:27:06 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
    2021-02-10 贺兰尚

    haohaoxuexiyixia

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=973119, encodeId=69eb9e311988, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9f5004226, createdName=xiexuejian, createdTime=Sat Jun 12 18:12:12 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969782, encodeId=d659969e8204, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/cf5b64396ba147d4aea7ea608f9198d3/c02bd27d4ef141ac99b6e8b6a5a74cba.jpg, createdBy=06f95413118, createdName=小铁1989, createdTime=Mon May 31 08:38:56 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954379, encodeId=9e719543e99a, content=对工作非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc302156663, createdName=12022708m82暂无昵称, createdTime=Wed Apr 07 08:32:27 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924117, encodeId=66e392411ed6, content=haohaoxuexiyixia, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87685391168, createdName=贺兰尚, createdTime=Wed Feb 10 22:52:10 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923249, encodeId=1d4d9232494f, content=真及时啊，正在找它, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210206/09bec44c50714aa99fcca057e007532f/345491d1e9e4465a8b0be3617b3ea5bd.jpg, createdBy=61a05458344, createdName=MrSxue, createdTime=Sat Feb 06 14:27:06 CST 2021, time=2021-02-06, status=1, ipAttribution=)]
    2021-02-06 MrSxue

    真及时啊，正在找它

    0

相关指南

卵圆孔未闭相关卒中预防中国专家指南

暂未更新 · 2021-01-10

2020 AAN指南：卵圆孔未闭和继发性卒中的预防

美国神经病学学会(AAN,American Academy of Neurology) · 2020-04-29

卵圆孔未闭预防性封堵术中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2017-03-30

拓展阅读

卵圆孔未闭预防性封堵术中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2017-03-30

2020 AAN指南：卵圆孔未闭和继发性卒中的预防

美国神经病学学会(AAN,American Academy of Neurology) · 2020-04-29

卵圆孔未闭相关卒中预防中国专家指南

暂未更新 · 2021-01-10

2022 SCAI指南：卵圆孔未闭的管理

美国心血管造影和介入学会(SCAI,Society for Cardiovascular Angiography and Interventions) · 2022-05-19

卵圆孔未闭右心声学造影中国专家共识

经食道超声心动图临床应用的中国专家共识专家组 · 2022-05-24

卵圆孔未闭超声诊断中国专家共识

中国医师协会心血管内科医师分会结构性心脏病学组 · 2023-01-27